Pharmabiz

Xcision Medical's GammaPod stereotactic radiotherapy system receives CE mark for breast cancer treatment

Systems LLC, a medical technology company, announced that the GammaPod stereotactic radiotherapy system has received CE marking, paving the way for new sales in Europe and offering patients the latest ...
Kansas City Star

New medical device headed to KU could be ‘revolutionary’ tool for breast cancer

It hasn’t been tried on a single patient yet, and already doctors are calling this new radiation therapy device for breast cancer “paradigm-changing” and “revolutionary.” It’s the GammaPod, coming ...
Business Insider

Xcision Receives FDA 510(k) Clearance for the GammaPod Stereotactic Radiotherapy System for Breast Cancer

COLUMBIA, Md., Jan. 9, 2018 /PRNewswire/ -- Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized ...
Pharmabiz

US FDA clears Xcision's GammaPod Stereotactic Radiotherapy System for breast cancer

Xcision Medical Systems, LLC has announced that the GammaPod Stereotactic Radiotherapy System, the world's first noninvasive external beam system optimized for partial breast treatments, has received ...
The Business Journals

Groundbreaking therapy for early-stage breast cancer results in shorter treatment schedule, fewer side effects, better cosmetic outcomes

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Allegheny Health Network (AHN) is one of the first medical ...
PR Newswire

GammaPod Stereotactic Radiotherapy System for Breast Cancer Receives CE Mark

Xcision to Highlight Short, Noninvasive and Patient Friendly Treatment Option at ESTRO 38 in Milan, Italy from April 26-30 "We are excited to bring GammaPod to the European market, where the need for ...